Home
Home

Paladin

Paladin Labs Announces Canadian Approval for Silenor

Paladin Labs Announces Canadian Approval for Silenor
Yahoo

Paladin Announces Agreement for Novel OTC Product to Treat Cold Sores

Paladin Announces Agreement for Novel OTC Product to Treat Cold Sores
Melodika

Paladin Labs signs agreement with QRxPharma for acute pain product

Paladin Labs signs agreement with QRxPharma for acute pain product
equities.com

Paladin looks beyond Canada

Paladin looks beyond Canada
Windsor Star, Canada

Paladin and Somaxon Announce Filing of New Drug Submission for Silenor

Paladin and Somaxon Announce Filing of New Drug Submission for Silenor
Yahoo

Valeant Pharma Offer Tops Paladin's

Valeant Pharma Offer Tops Paladin's
Yahoo/Zacks.com

Paladin Considers Options Following Alternate Offer for Afexa

Paladin Considers Options Following Alternate Offer for Afexa
Stock Markets Review

Valeant emerges as Afexa's $76M white knight

Valeant emerges as Afexa's $76M white knight
Fierce Pharma

Paladin Labs CEO in serious accident

Paladin Labs CEO in serious accident
Financial Post, Canada

Paladin makes hostile bid for Afexa

Paladin makes hostile bid for Afexa
Fierce Biotech